| | ENG

For Investigators Only

CN103: Phase III Cord Blood Mononuclear Cells ± Lithium Trial
Provided regulatory approvals and adequate funds are available, ChinaSCINet whishes to start the pivotal Phase III clinical trial in Mainland China, Hong Kong and Taiwan in the near future. This study is to assess the efficacy of umbilical cord blood mononuclear cell transplants with or without lithium followed by intensive locomotion training in 120 patients with chronic spinal cord injury.

The Study is Expected to have:

Study Sites: from Mainland China, Hong Kong and Taiwan

Principal Investigators: to be determined

Estimated No. of Subjects: 120

What should I do if I would like to participate in the trials of ChinaSCINet?
To learn as much as possible about the clinical trial and then contact the investigator directly. You may also leave your basic information and contact here (Submit a Form). The investigators may retrieve the data and contact you if they think you might be suitable candidate for the trial.

To read more:

About Clinical Research

About Lithium and Cord Blood Cells
Copyright © 2020. CHINASCINET
About Us | SCI Info | Studies | Events | ISCITT | Contact